The ADHD drug market is already stretched thin. Now it's facing a back-to-school supply strain
[ad_1]
Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc. Jb Reed | Bloomberg | Getty Images It's been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — one of the most widely used medications for attention deficit hyperactivity disorder — and the supply strain could potentially worsen in the months ahead. While some supply issues have improved, many Americans are still struggling to find and fill prescriptions for the drug and other medications for ADHD that they often rely on to stay focused and complete daily tasks. Drug-shortage experts told CNBC that it's extremely difficult to forecast how much longer the shortages will last because of the lack of transparency in the pharmaceutical industry — and some are concerned about market conditions as children, who are commonly affected by ADHD, head back to school. "Unfortunately, we might see the shortage worsen. We are heading into